✦ LIBER ✦

Apoptosis signal-regulating kinase-1 inhibitor as a potent therapeutic drug for the treatment of gastric cancer

✍ Scribed by Hayakawa, Yoku; Hirata, Yoshihiro; Sakitani, Kosuke; Nakagawa, Hayato; Nakata, Wachiko; Kinoshita, Hiroto; Takahashi, Ryota; Takeda, Kohsuke; Ichijo, Hidenori; Maeda, Shin; Koike, Kazuhiko

Book ID: 119827171
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 432 KB
Volume: 103
Category: Article
ISSN: 1347-9032
DOI: 10.1111/cas.12024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PS1-030. Tyrosine kinase inhibitor SU666

PS1-030. Tyrosine kinase inhibitor SU6668 blocks the polyIC-induced IFNλ-expression of keratinocytes: TBK1 as a potential drug-target for the treatment of cutaneous lupus erythematosus

✍ Sabine Zahn; Jan Orthmann; Sonal Sharma; Thomas Tüting; Jörg Wenzel 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 34 KB

The Identification of 2-(1 H -Indazol-4-

The Identification of 2-(1 H -Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2- d ]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer †

✍ Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Ste 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 659 KB

[RSC Drug Discovery] New Therapeutic Str

[RSC Drug Discovery] New Therapeutic Strategies for Type 2 Diabetes Volume 74 || Chapter 11. The Discovery and Development of MB07803, a Second-Generation Fructose-1,6-bisphosphatase Inhibitor with Improved Pharmacokinetic Properties, as a Potential Treatment of Type 2 Diabetes

✍ Jones, Rob M 📂 Article 📅 2012 🏛 Royal Society of Chemistry ⚖ 720 KB